Package 62332-816-91

{"route": ["ORAL"], "spl_id": "2cb5f610-f979-488a-9adf-23ba4f81b772", "openfda": {"upc": ["0362332816316", "0362332815319"], "unii": ["OLH94387TE"], "rxcui": ["830837", "830845", "830861"], "spl_set_id": ["04a85be5-f746-418e-8e37-292703f16934"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-816-31)", "package_ndc": "62332-816-31", "marketing_start_date": "20241028"}, {"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-816-71)", "package_ndc": "62332-816-71", "marketing_start_date": "20241028"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-816-91)", "package_ndc": "62332-816-91", "marketing_start_date": "20241028"}], "brand_name": "Diltiazem Hydrochloride", "product_id": "62332-816_2cb5f610-f979-488a-9adf-23ba4f81b772", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "62332-816", "generic_name": "Diltiazem Hydrochloride", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Diltiazem Hydrochloride", "active_ingredients": [{"name": "DILTIAZEM HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA218587", "marketing_category": "ANDA", "marketing_start_date": "20241028", "listing_expiration_date": "20261231"}